
Mickle Felix Pharmaceuticals Private Limited
Manufactures chemicals, compounds, and pharmaceuticals with registered office in Delhi.
Manufactures chemicals, compounds, and pharmaceuticals with registered office in Delhi.
Mickle Felix Pharmaceuticals Private Limited (MFPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2004 and has a history of 20 years and 11 months. Its registered office is in Delhi, India.
The Corporate was formerly known as Niramaya Pharmaceuticals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gurcharan Singh, Gajendra Shekhawat, and Mohinder Singh serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24239DL2004PTC125291
125291
Private Limited Indian Non-Government Company
19 Mar 2004
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Mickle Felix Pharmaceuticals Private Limited offers a wide range of products and services, including Sexual Wellness Products, Erectile Dysfunction Medicine, Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gajendra Shekhawat ![]() | Director | 25-Sep-2024 | Current |
Gurcharan Singh ![]() | Director | 01-Jan-2014 | Current |
Mohinder Singh ![]() | Director | 02-Apr-2021 | Current |
Mickle Felix Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 96.93% decrease. The company also saw a substantial fall in profitability, with a 25.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.07%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Mickle Felix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gurcharan Singh and Mohinder Singh are mutual person
₹0
₹4.00 Cr
Date | Lender | Amount | Status |
---|---|---|---|
15 Dec 2004 | Punjab National Bank | ₹4.00 Cr | Satisfied |
Mickle Felix Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mickle Felix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mickle Felix Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mickle Felix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Gajendra Singh Shekhawat was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 5 months 11 days .
Mickle Felix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Mohinder Singh was appointed as a Director was appointed as a Director on 02 Apr 2021 & has been associated with this company since 3 years 11 months .
A charge registered on 15 Dec 2004 via Charge ID 90039623 with Punjab National Bank was fully satisfied on 26 Nov 2014.
Gurcharan Singh was appointed as a Director was appointed as a Director on 01 Jan 2014 & has been associated with this company since 11 years 2 months .
Mickle Felix Pharmaceuticals Private Limited was incorporated on 19 Mar 2004.
The authorized share capital of Mickle Felix Pharmaceuticals Private Limited is ₹ 4.00 Cr and paid-up capital is ₹ 4.00 Cr.
Currently 3 directors are associated with Mickle Felix Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mickle Felix Pharmaceuticals Private Limited is 103 Friends Complex E-7A Jawahar Park Laxmi Nagar, India, Delhi, 110092.
The corporate identification number (CIN) of Mickle Felix Pharmaceuticals Private Limited is U24239DL2004PTC125291 and the company number is 125291 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Mickle Felix Pharmaceuticals Private Limited has fallen by -96.93%.
As Per 2020 financial reports, 11 employees are currently employed by Mickle Felix Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2020 indicates that The net worth of Mickle Felix Pharmaceuticals Private Limited has experienced an downturn of -63.07%.
The most recent Balance Sheet for Mickle Felix Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
PA
MJ
KG
AB
HS
DK